A NEW breast cancer treatment could help thousands of women because it slashes the risk of the disease returning by a quarter, a new study has revealed.2Credit: Getty Images - GettyPatients with hormone receptor positive early stage breast cancer at a high risk of recurrence were recruited.
Just 11.3 per cent of patients who participated suffered a relapse compared with 7.8 per cent in the abemaciclib group.Credit: PA:Press Association The report stated: "Patients with disease that has spread to lymph nodes, a large tumour size at the time of diagnosis, or an increased cellular proliferation were considered to be at 'high risk' of recurrence and recruited to the study".
Nearly 1,000 people die from breast cancer every month in the UK, with the disease killing around 11,500 women and 80 men each year.